Skip to main content
Universal Drugstore logo

Why pay full price for medications?

See Prices Now

U.S. Closes Import Route Behind Millions in Canadian Prescription Savings

For years, Americans facing high prescription drug prices have looked north for relief.

Shop Medications

Patients with a valid personal prescription have ordered medications from licensed Canadian pharmacies, sometimes paying substantially less than they would at a U.S. pharmacy. That long-standing route to cheaper prescription medications is now facing a major disruption.

Beginning October 22, 2026, new U.S. customs-entry requirements are expected to make it significantly more difficult for Canadian and other international pharmacies to mail prescription medications directly to American patients.

The change does not create a new ban on importing drugs from Canada. Importing foreign versions of prescription drugs has generally been prohibited under federal law, with the U.S. Food and Drug Administration exercising enforcement discretion in limited personal-use situations.

Why Pay Full Price?

Search our full medication catalogue and save up to 80% - no insurance needed.

See Prices Now

What is changing is the customs system that allowed many small prescription packages to move through international mail with relatively little interference. For patients who have relied on Canadian pharmacies to manage high medication costs, that distinction may matter less than the practical result: their prescriptions may no longer arrive.

Key Takeaways

  • New U.S. customs procedures from the Trump administration taking effect October 22, 2026, could effectively halt many personal prescription shipments from Canadian pharmacies.
  • The change affects shipping and customs entry rather than creating a new blanket prohibition on Canadian prescription medications.
  • Personal drug import has long existed in a legal gray area, with the FDA exercising enforcement discretion in limited circumstances.
  • More than 2 million Americans were estimated to have purchased prescription drugs outside the U.S. in previous research.
  • Patient advocates say Americans can save substantially on certain brand-name drugs by purchasing from licensed Canadian pharmacies.
  • The changes do not eliminate separate government-authorized programs allowing states and tribes to pursue prescription drug importation from Canada.

A Quiet Source of Prescription Savings

Ordering prescription medications from Canada has never operated like filling a prescription at a neighborhood U.S. pharmacy.

Federal law strictly limits the importation of prescription drugs through the Food, Drug, and Cosmetic Act. However, the FDA has historically used enforcement discretion for certain personal imports.

Among other factors, the FDA considers whether a medication is intended for a serious condition, whether effective treatment is available domestically, whether the drug presents an unreasonable risk, and whether the patient is generally importing no more than a three-month supply for personal use.

That policy helped create an unusual system: personal prescription importation was restricted under federal law, yet some shipments were allowed into the country on a case-by-case basis.

Over time, Canadian pharmacies and international pharmacy services built businesses serving U.S. patients seeking lower prices.

Why October 22 Changes the System

The immediate issue involves changes to the Department of Homeland Security (DHS) and U.S. Customs and Border Protection (CBP) procedures for low-value international shipments.

The federal government suspended the longstanding de minimis exemption that had simplified entry for merchandise valued at $800 or less. CBP subsequently established new entry requirements for international postal shipments.

Beginning October 22, provisions of those rules affecting shipments that require information for other government agencies, including the FDA, reach their compliance date.

The Canadian International Pharmacy Association, or CIPA, says the new requirements will make the existing prescription delivery model unworkable for most of its members.

According to CIPA, prescription shipments would face a more complicated customs process requiring an eligible importer of record, customs-broker involvement, a financial guarantee or customs bond, electronic filings, and applicable regulatory information.

For an individual ordering a 90-day supply of medication, those requirements can transform what was once a relatively simple mail-order transaction into one that is difficult or uneconomical to process.

Why Americans Have Turned to Canadian Pharmacies

The answer is simple. Prices for many popular brand-name drugs in the U.S. are ridiculously high, while the Health Canada-approved versions are a fraction of the cost.

An August 2026 analysis by the Campaign for Personal Prescription Importation compared 90-day supplies of 10 commonly prescribed brand-name medications. The advocacy group reported average savings of 65% when the medications were purchased through licensed Canadian pharmacies rather than at the U.S. prices included in its comparison.

Those findings come with an important limitation: the study was conducted by an organization that advocates for personal prescription importation, rather than by an independent government agency.

Still, the underlying U.S.-Canada price gap for many medicines has been one of the main forces driving Americans to search for cheap medications abroad.

Research published in JAMA Network Open previously estimated that more than 2 million U.S. adults purchased prescription drugs outside the country to save money.

The Impact Could Be Felt Quickly

For patients taking inexpensive generic medications, losing access to Canadian pharmacies may have little effect. For those taking costly brand-name drugs that have high copays or are not covered by insurance, the financial difference can be substantial.

That makes the issue about more than finding the lowest price.

Patients who suddenly lose access to an affordable medication may have to ask their healthcare provider about an alternative treatment, seek manufacturer assistance, appeal an insurance decision, or pay a significantly higher U.S. price.

Patient advocates have warned that some people could respond by rationing medication or delaying treatment.

The change comes as affordability remains a persistent problem in the U.S. prescription market. A 2026 JAMA study examining more than 2 million attempts to fill single-source brand-name prescriptions found that 32% were initially rejected because of formulary restrictions, prior authorization, or step-therapy requirements. Nearly half of those patients did not receive the originally prescribed drug or another drug in the same therapeutic class within 90 days.

Canadian Importation Isn’t Ending Entirely

There is another important distinction in the drug import debate.

The personal mail-order route is separate from the FDA’s Section 804 Importation Program.

Under Section 804, states and Indian tribes can seek FDA authorization to establish programs importing certain prescription medications from Canada if they can demonstrate significant cost savings without creating additional risks to public health and safety.

The federal government has recently been working to expand that pathway. In March 2026, the FDA met with states interested in Canadian prescription drug import programs and discussed ways to streamline authorization.

That creates an unusual contrast: Washington is encouraging formal, government-supervised Canadian drug import programs at the same time customs changes threaten the informal personal-import route Americans have used for years.

What Patients Who Order From Canada Should Know

Patients who currently receive prescription medications by mail from Canadian pharmacies should check with their pharmacy well before October 22 to determine whether their orders may be affected.

The change does not necessarily mean every prescription package will automatically be seized at the border. The FDA says personal imports will continue to be evaluated under its existing policies, and admissibility ultimately depends on the circumstances of the shipment.

But Canadian pharmacy organizations say the practical problem occurs earlier in the process: the customs and brokerage requirements may prevent many routine shipments from being processed at all.

The rules also do not necessarily prevent an American traveler from returning from Canada with medication for personal use. Different rules and enforcement considerations apply to medications physically carried across the border.

A Drug-Pricing Issue That Isn’t Going Away

The October change highlights a larger contradiction in the U.S. prescription drug market.

Americans have access to many of the world’s newest medications, but some patients continue to look outside the country because they cannot afford the U.S. price.

Canadian pharmacies became one workaround for that problem. They did not solve the underlying causes of high prescription costs, and personal drug import remained legally restricted. But for some Americans, the savings were substantial enough to make the complicated system worthwhile.

Now that route could become considerably narrower.

Unless implementation changes before October 22, patients who have depended on international mail-order prescriptions may soon have to find another way to afford their medications.

Sources